Free Trial

Danaher Corporation (NYSE:DHR) Shares Bought by Live Oak Private Wealth LLC

Danaher logo with Medical background

Live Oak Private Wealth LLC lifted its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 3.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 45,506 shares of the conglomerate's stock after purchasing an additional 1,717 shares during the quarter. Danaher comprises approximately 1.5% of Live Oak Private Wealth LLC's investment portfolio, making the stock its 20th biggest position. Live Oak Private Wealth LLC's holdings in Danaher were worth $9,329,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher during the 4th quarter worth $27,000. Rialto Wealth Management LLC purchased a new position in shares of Danaher during the 4th quarter worth $34,000. Hurley Capital LLC purchased a new position in shares of Danaher during the 4th quarter worth $34,000. Dunhill Financial LLC grew its holdings in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the period. Finally, Ameriflex Group Inc. purchased a new position in shares of Danaher during the 4th quarter worth $38,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Argus lowered their target price on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Wall Street Zen cut Danaher from a "buy" rating to a "hold" rating in a report on Monday, June 9th. The Goldman Sachs Group lowered their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered their target price on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Barclays restated an "overweight" rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and a consensus target price of $248.61.

Check Out Our Latest Research Report on DHR

Insider Transactions at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Danaher Stock Up 0.4%

Shares of DHR traded up $0.88 during midday trading on Thursday, hitting $201.88. The company had a trading volume of 5,562,250 shares, compared to its average volume of 3,497,229. The company's 50-day simple moving average is $194.61 and its 200-day simple moving average is $208.77. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The firm has a market capitalization of $144.48 billion, a P/E ratio of 39.20, a P/E/G ratio of 2.82 and a beta of 0.77. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines